Oryzon Genomics S A : reports financial results and corporate update for quarter ended March 31, 2024
6 May 2024 ORYZON reports financial results and corporate update for quarter ended March 31, 2024 Finalizing full data analysis from...
Stay updated with breaking news from Recommended Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
6 May 2024 ORYZON reports financial results and corporate update for quarter ended March 31, 2024 Finalizing full data analysis from...
BrightRock Gold Corp. Releases Phase 1 Exploration Report on the Midnight ...
/PRNewswire/ -- Immunitas Therapeutics ("Immunitas"), a clinical stage precision immunotherapy company committed to discovering and developing novel,...
Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that through its collaboration agreement with a...
/PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of...